#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Czechia Denmark Finland France +10

  • Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +7

  • Study of isatuximab, belumosudil and dexamethasone combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Norway Portugal

  • Study of isatuximab, evorpacept and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Norway Portugal

  • Study of isatuximab, pomalidomide and dexamethasone combination for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Norway Portugal

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +11

  • Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France Italy Poland Spain

  • A study of Cesnicabtagene autoleucel compared to a drug combination for patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy